Trial Profile
A Retrospective Study To Compare the Effects of Sugammadex vs. Pyridostigmine–Glycopyrrolate On Post-Operative Nausea And Vomiting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2016
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Glycopyrrolate; Pyridostigmine
- Indications Neuromuscular blockade; Postoperative nausea and vomiting
- Focus Therapeutic Use
- 28 Oct 2016 New trial record
- 02 Oct 2016 Results published in the Acta Anaesthesiologica Scandinavica Journal.